Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster

Author:

Gershon Anne A1,Gershon Michael D1,Shapiro Eugene D2

Affiliation:

1. Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA

2. Yale School of Medicine, New Haven, Connecticut, USA

Abstract

Abstract Michiaki Takahashi developed the live attenuated varicella vaccine in 1974 . This was the first, and is still the only, herpesvirus vaccine. Early studies showed promise, but the vaccine was rigorously tested on immunosuppressed patients because of their high risk of fatal varicella; vaccination proved to be lifesaving. Subsequently, the vaccine was found to be safe and effective in healthy children. Eventually, varicella vaccine became a component of measles mumps rubella vaccine, 2 doses of which are administered in the USA to ~90% of children. The incidence of varicella has dropped dramatically in the USA since vaccine-licensure in 1995. Varicella vaccine is also associated with a decreased incidence of zoster and is protective for susceptible adults. Today, immunocompromised individuals are protected against varicella due to vaccine-induced herd immunity. Latent infection with varicella zoster virus occurs after vaccination; however, the vaccine strain is impaired for its ability to reactivate.

Funder

National Center for Advancing Translational Science

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference53 articles.

1. Use of saliva to identify varicella zoster virus infection of the gut;Gershon;Clin Infect Dis,2015

2. Modification of chicken pox in family contacts by administration of gamma globulin;Ross;N Engl J Med,1962

3. Prevention of varicella by zoster immune globulin;Brunell;N Engl J Med,1969

4. Zoster immune globulin. A further assessment;Gershon;N Engl J Med,1974

5. Varicella in children with cancer: impact of antiviral therapy and prophylaxis;Feldman;Pediatrics,1987

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3